183 related articles for article (PubMed ID: 16642533)
21. Synthesis and antibody recognition of synthetic antigens from MUC1.
Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
[TBL] [Abstract][Full Text] [Related]
22. Conformational effects of the non-natural alpha-methylserine on small peptides and glycopeptides.
Fernández-Tejada A; Corzana F; Busto JH; Avenoza A; Peregrina JM
J Org Chem; 2009 Dec; 74(24):9305-13. PubMed ID: 19924838
[TBL] [Abstract][Full Text] [Related]
23. Localization of O-glycans in MUC1 glycoproteins using electron-capture dissociation fragmentation mass spectrometry.
Sihlbom C; van Dijk Härd I; Lidell ME; Noll T; Hansson GC; Bäckström M
Glycobiology; 2009 Apr; 19(4):375-81. PubMed ID: 19095697
[TBL] [Abstract][Full Text] [Related]
24. Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.
Liu X; Sejbal J; Kotovych G; Koganty RR; Reddish MA; Jackson L; Gandhi SS; Mendonca AJ; Longenecker BM
Glycoconj J; 1995 Oct; 12(5):607-17. PubMed ID: 8595249
[TBL] [Abstract][Full Text] [Related]
25. Efficient substitution reaction from cysteine to the serine residue of glycosylated polypeptide: repetitive peptide segment ligation strategy and the synthesis of glycosylated tetracontapeptide having acid labile sialyl-T(N) antigens.
Okamoto R; Souma S; Kajihara Y
J Org Chem; 2009 Mar; 74(6):2494-501. PubMed ID: 19236026
[TBL] [Abstract][Full Text] [Related]
26. NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.
Naganagowda GA; Gururaja TL; Satyanarayana J; Levine MJ
J Pept Res; 1999 Oct; 54(4):290-310. PubMed ID: 10532235
[TBL] [Abstract][Full Text] [Related]
27. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen.
Schuman JT; Grinstead JS; Apostolopoulos V; Campbell AP
Biopolymers; 2005 Feb; 77(2):107-20. PubMed ID: 15635690
[TBL] [Abstract][Full Text] [Related]
28. Parallel solid-phase synthesis of mucin-like glycopeptides.
Liu M; Barany G; Live D
Carbohydr Res; 2005 Sep; 340(13):2111-22. PubMed ID: 16026772
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of MUC1 glycopeptide thioesters and ligation via direct aminolysis.
Wilkinson BL; Chun CK; Payne RJ
Biopolymers; 2011; 96(2):137-46. PubMed ID: 20564042
[TBL] [Abstract][Full Text] [Related]
30. Design of a MUC1-based cancer vaccine.
Hanisch FG
Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
[TBL] [Abstract][Full Text] [Related]
31. Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety.
Rojas-Ocáriz V; Compañón I; Aydillo C; Castro-Loṕez J; Jiménez-Barbero J; Hurtado-Guerrero R; Avenoza A; Zurbano MM; Peregrina JM; Busto JH; Corzana F
J Org Chem; 2016 Jul; 81(14):5929-41. PubMed ID: 27305427
[TBL] [Abstract][Full Text] [Related]
32. Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions.
Grinstead JS; Koganty RR; Krantz MJ; Longenecker BM; Campbell AP
Biochemistry; 2002 Aug; 41(31):9946-61. PubMed ID: 12146959
[TBL] [Abstract][Full Text] [Related]
33. Conformational studies by NMR of the antimicrobial peptide, drosocin, and its non-glycosylated derivative: effects of glycosylation on solution conformation.
McManus AM; Otvos L; Hoffmann R; Craik DJ
Biochemistry; 1999 Jan; 38(2):705-14. PubMed ID: 9888811
[TBL] [Abstract][Full Text] [Related]
34. Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope.
Singh J; Her C; Supekar N; Boons GJ; Krishnan VV; Brooks CL
J Pept Sci; 2020 Jan; 26(1):e3229. PubMed ID: 31729101
[TBL] [Abstract][Full Text] [Related]
35. Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.
Marcelo F; Garcia-Martin F; Matsushita T; Sardinha J; Coelho H; Oude-Vrielink A; Koller C; André S; Cabrita EJ; Gabius HJ; Nishimura S; Jiménez-Barbero J; Cañada FJ
Chemistry; 2014 Dec; 20(49):16147-55. PubMed ID: 25324212
[TBL] [Abstract][Full Text] [Related]
36. Fluorinated glycosyl amino acids for mucin-like glycopeptide antigen analogues.
Wagner S; Mersch C; Hoffmann-Röder A
Chemistry; 2010 Jun; 16(24):7319-30. PubMed ID: 20461825
[TBL] [Abstract][Full Text] [Related]
37. Formation of lactones from sialylated MUC1 glycopeptides.
Pudelko M; Lindgren A; Tengel T; Reis CA; Elofsson M; Kihlberg J
Org Biomol Chem; 2006 Feb; 4(4):713-20. PubMed ID: 16467946
[TBL] [Abstract][Full Text] [Related]
38. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
Zhou D; Xu L; Huang W; Tonn T
Molecules; 2018 May; 23(6):. PubMed ID: 29857542
[TBL] [Abstract][Full Text] [Related]
39. The contribution of tandem repeat number to the O-glycosylation of mucins.
Silverman HS; Sutton-Smith M; McDermott K; Heal P; Leir SH; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2003 Apr; 13(4):265-77. PubMed ID: 12626424
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of the glycosylated forms of MUC1 during lung development.
Sakurai J; Hattori N; Nakajima M; Moriya T; Suzuki T; Yokoyama A; Kohno N
Eur J Histochem; 2007; 51(2):95-102. PubMed ID: 17664159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
